![Sergey Yurasov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 53 462 $ au 31/05/2026
Sergey Yurasov currently works at Black Diamond Therapeutics, Inc., as Chief Medical Officer from 2022.
Dr. Yurasov also formerly worked at Hoffman-La Roche, Inc., as Clinical Director-Oncology & Pharma Research, ImClone LLC, as Associate Vice President-Global Medicine Science, The Rockefeller University, as Assistant Professor-Clinical Investigation, Immune Design Corp., as Chief Medical Officer & SVP-Clinical Development from 2016 to 2019, Clovis Oncology, Inc., as Senior Vice President-Clinical Development in 2016, and Nuvation Bio, Inc., as Chief Medical Officer from 2019 to 2022.
Dr. Yurasov received his doctorate degree from Russian State Medical University and doctorate degree from Research Institute for Pediatric Oncology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 24 082 ( 0,04 % ) | 53 462 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| NUVATION BIO INC. | Directeur Technique/Scientifique/R&D | 01/02/2022 |
| IMMUNE DESIGN CORP | Directeur Technique/Scientifique/R&D | 02/04/2019 |
| CLOVIS ONCOLOGY, INC. | Corporate Officer/Principal | 01/09/2016 |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Hoffman-La Roche, Inc.
 Hoffman-La Roche, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines, diagnostics and vitamins | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Russian State Medical University
 Russian State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Hoffman-La Roche, Inc.
Hoffman-La Roche, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines, diagnostics and vitamins | Health Technology |
Research Institute for Pediatric Oncology
 Research Institute for Pediatric Oncology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
